Product

How it works
Pricing
For Providers
Trials

Company

About
Blog
FAQ

Legal

Clareo Health | Breast Cancer Clinical Trials in Arizona | 707 Studies

Clinical Trials Breast CancerArizona

Breast Cancer Clinical Trials in Arizona

Find 707 clinical trials for breast cancer near Arizona. Connect with research centers in your area.

All Breast Cancer trials nationwide All trials in Arizona

Order

Status

RecruitingNot yet recruitingActive, not recruitingEnrolling by invitationCompletedTerminated

Phase

Early phase 1Phase 1Phase 1–2Phase 2Phase 2–3Phase 3Phase 4Not applicable

Who can join

Healthy volunteers too

Showing 201-220 of 707 trials

TerminatedDose Escalation and Expansion Study of GSK525762 in Combination With Fulvestrant in Participants With Hormone Receptor-positive (HR+)/Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Advanced or Metastatic Breast CancerThis is a combination Phase I and Phase II study, with an aim to evaluate the combination of GSK525762 and fulvestrant in women with HR+/HER2- advanced or metastatic breast…NCT02964507·Birmingham, Alabama and 37 others

Breast Cancer Trials in Other Cities

New York Los Angeles Chicago Houston Phoenix Philadelphia

Data from ClinicalTrials.govTerms

CompletedA Study of Paclitaxel With GDC-0941 Versus Paclitaxel With Placebo in Participants With Locally Recurrent or Metastatic Breast CancerThis multicenter, randomized, single-blind, placebo-controlled, two arm study will evaluate the efficacy and safety of paclitaxel with GDC-0941 versus paclitaxel with placebo in…NCT01740336·Sedona, Arizona and 96 others

TerminatedThe CAT Study: Atamestane Plus Toremifene Versus Letrozole in Advanced Breast CancerThe purpose of this study is to determine whether maximal estrogen suppression achieved via the combination of an experimental drug, atamestane, plus an FDA-approved drug…NCT00097344·Mobile, Alabama and 103 others

RecruitingA Study to Evaluate the Efficacy and Safety of Inavolisib in Combination With Phesgo Versus Placebo in Combination With Phesgo in Participants With PIK3CA-Mutated HER2-Positive Locally Advanced or Metastatic Breast CancerThis study will evaluate the efficacy and safety of inavolisib in combination with Phesgo (pertuzumab, trastuzumab, and rHuPH20 injection for subcutaneous use) compared with…NCT05894239·Gilbert, Arizona and 191 others

CompletedPhase 3 Trial of Elacestrant Versus Standard of Care for the Treatment of ER+/HER2- Advanced Breast CancerThis Phase 3 clinical study compares the efficacy and safety of elacestrant to the standard of care (SoC) options of fulvestrant or an aromatase inhibitor (AI) in women and men…NCT03778931·Tucson, Arizona and 243 others

Active not recruitingDNA-guided Second Line Adjuvant Therapy for High Residual Risk, Estrogen Receptor Positive, HER-2 Negative Breast Cancer (DARE)A randomized, Phase II trial of circulating tumor DNA-guided second line Adjuvant therapy for high Residual risk, Estrogen Receptor positive, HER-2 negative breast cancer (DARE)NCT04567420·Tucson, Arizona and 18 others

TerminatedTesting the Use of Fulvestrant and Binimetinib Targeted Treatment for NF1 Mutation in Hormone Receptor-Positive Metastatic Breast Cancer (A ComboMATCH Treatment Trial)This phase II ComboMATCH treatment trial compares the usual treatment alone (fulvestrant) to using binimetinib plus the usual treatment in patients with hormone receptor positive…NCT05554354·Birmingham, Alabama and 195 others

CompletedProne Breath Hold Technique to Decrease Cardiac and Pulmonary Doses in Women Receiving Left Breast RadiotherapyThis is a pilot study to determine whether the addition of inspiratory hold (breath holding) can decrease the radiation dose that the heart and lung receive for patients being…NCT02379988·Tucson, Arizona

Active not recruitingStudy of Pembrolizumab (MK-3475) Versus Placebo in Combination With Neoadjuvant Chemotherapy & Adjuvant Endocrine Therapy in the Treatment of Early-Stage Estrogen Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative (ER+/HER2-) Breast Cancer (MK-3475-756/KEYNOTE-756)The purpose of this study is to assess the efficacy and safety of pembrolizumab (MK-3475) versus placebo in combination with neoadjuvant (pre-surgery) chemotherapy and adjuvant…NCT03725059·Daphne, Alabama and 243 others

CompletedStudy of Icrucumab (IMC-18F1) or Ramucirumab Drug Product (DP) in Combination With Capecitabine or Capecitabine on Previously Treated Breast Cancer PatientsAn open-label, multicenter, randomized, Phase 2 trial in which participant with unresectable, locally advanced or metastatic breast cancer who have been previously treated with…NCT01234402·Scottsdale, Arizona and 22 others

CompletedMifepristone and Eribulin in Patients With Metastatic Triple Negative Breast Cancer or Other Specified Solid TumorsThis is a study to assess the safety of the combination of mifepristone and eribulin in patients with metastatic or locally advanced unresectable breast or other specified solid…NCT02014337·Tucson, Arizona and 10 others

RecruitingTrial of 225Ac-DOTATATE (RYZ101) in Subjects With ER+, HER2-negative Unresectable or Metastatic Breast Cancer Expressing SSTRs.Phase 1b/2 open-label trial of 225Ac-DOTATATE (RYZ101) in subjects with ER+, HER2-negative unresectable or metastatic breast cancer expressing SSTRs.NCT06590857·Phoenix, Arizona and 30 others

CompletedNanoparticle Albumin-Bound Rapamycin in Treating Patients With Advanced Cancer With mTOR MutationsThis pilot trial studies how well nanoparticle albumin-bound rapamycin works in treating patients with cancer that as has spread to other places in the body and usually cannot be…NCT02646319·Scottsdale, Arizona and 1 other

CompletedPyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other CancerRATIONALE: Pyridoxine (vitamin B6) and topical urea/lactic acid-based cream may prevent or lessen hand-foot syndrome caused by chemotherapy.NCT00296036·Scottsdale, Arizona and 230 others

RecruitingA Study of Sofe-M in Participants With Selected Advanced Solid TumorsThe purpose of this study is to find out whether the study drug, Sofetabart Mipitecan (LY4170156), is safe, tolerable and effective in participants with advanced solid tumors.NCT06400472·Scottsdale, Arizona and 24 others

CompletedMagnesium Oxide in Treating Postmenopausal Women With Hot Flashes and a History of Breast CancerRATIONALE: Magnesium oxide may help relieve hot flashes symptoms in women with a history of breast cancer.NCT01439945·Fairbanks, Alaska and 282 others

CompletedA Study to Evaluate the Safety and Tolerability of Immunotherapy Combinations in Participants With Advanced MalignanciesThis is a Phase 1, open-label, dose-escalation and dose-expansion study to evaluate the safety, tolerability, pharmacokinetic (PK), pharmacodynamic (PD) and clinical activity of…NCT03629756·Scottsdale, Arizona and 14 others

CompletedComparison of Combination Chemotherapy Regimens in Treating Older Women Who Have Undergone Surgery for Breast CancerRATIONALE: Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.NCT00024102·Birmingham, Alabama and 333 others

CompletedA Study Evaluating Safety, Pharmacokinetics, and Therapeutic Activity of RO6874281 as a Single Agent (Part A) or in Combination With Trastuzumab or Cetuximab (Part B or C)This first-in-human, open-label, multicenter, Phase Ia/Ib, adaptive, multiple ascending-dose study will evaluate the safety, tolerability, pharmacokinetics (PK), pharmacodynamics…NCT02627274·Tucson, Arizona and 25 others

Active not recruitingS1207 Hormone Therapy With or Without Everolimus in Treating Patients With Breast CancerRATIONALE: Estrogen can cause the growth of breast cancer cells.NCT01674140·Birmingham, Alabama and 1457 others

PreviousPage 11 of 36Next

Other Conditions in Arizona

Lung Cancer Prostate Cancer Colorectal Cancer Melanoma Leukemia Lymphoma